408 related articles for article (PubMed ID: 24907488)
21. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of MCB3681 against Clostridium difficile strains.
Rashid MU; Dalhoff A; Weintraub A; Nord CE
Anaerobe; 2014 Aug; 28():216-9. PubMed ID: 25016084
[TBL] [Abstract][Full Text] [Related]
23. Shedding of Clostridium difficile PCR ribotype 078 by zoo animals, and report of an unstable metronidazole-resistant isolate from a zebra foal (Equus quagga burchellii).
Álvarez-Pérez S; Blanco JL; Martínez-Nevado E; Peláez T; Harmanus C; Kuijper E; García ME
Vet Microbiol; 2014 Mar; 169(3-4):218-22. PubMed ID: 24467928
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Clostridioides difficile ribotypes in domestic dogs in Rio de Janeiro, Brazil.
Rainha K; Fernandes Ferreira R; Trindade CNR; Carneiro LG; Penna B; Endres BT; Begum K; Alam MJ; Garey KW; Domingues Regina Maria CP; Ferreira EO
Anaerobe; 2019 Aug; 58():22-29. PubMed ID: 31220606
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
Mackin KE; Elliott B; Kotsanas D; Howden BP; Carter GP; Korman TM; Riley TV; Rood JI; Jenkin GA; Lyras D
Anaerobe; 2015 Aug; 34():80-3. PubMed ID: 25944720
[TBL] [Abstract][Full Text] [Related]
26. The epidemiology of Clostridium difficile in Scotland.
Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE
J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104
[TBL] [Abstract][Full Text] [Related]
27. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106.
Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J
J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938
[TBL] [Abstract][Full Text] [Related]
28. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.
Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A
J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381
[TBL] [Abstract][Full Text] [Related]
30. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
[TBL] [Abstract][Full Text] [Related]
31. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea.
Kim J; Kang JO; Kim H; Seo MR; Choi TY; Pai H; Kuijper EJ; Sanders I; Fawley W
Clin Microbiol Infect; 2013 Jun; 19(6):521-7. PubMed ID: 22712697
[TBL] [Abstract][Full Text] [Related]
33. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
[TBL] [Abstract][Full Text] [Related]
34. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
[TBL] [Abstract][Full Text] [Related]
35. The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
Novakova E; Stefkovicova M; Kopilec MG; Novak M; Kotlebova N; Kuijper E; Krutova M
Int J Infect Dis; 2020 Jan; 90():111-115. PubMed ID: 31707136
[TBL] [Abstract][Full Text] [Related]
36. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
[TBL] [Abstract][Full Text] [Related]
37. An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil.
Balassiano IT; Dos Santos-Filho J; de Oliveira MP; Ramos MC; Japiassu AM; Dos Reis AM; Brazier JS; de Oliveira Ferreira E; Domingues RM
Diagn Microbiol Infect Dis; 2010 Dec; 68(4):449-55. PubMed ID: 20884155
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
[TBL] [Abstract][Full Text] [Related]
39. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.
Carman RJ; Genheimer CW; Rafii F; Park M; Hiltonsmith MF; Lyerly DM
Anaerobe; 2009 Dec; 15(6):244-8. PubMed ID: 19818865
[TBL] [Abstract][Full Text] [Related]
40. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
Shoaei P; Shojaei H; Jalali M; Khorvash F; Hosseini SM; Ataei B; Vakili B; Ebrahimi F; Tavakoli H; Esfandiari Z; Weese JS
BMC Infect Dis; 2019 Apr; 19(1):361. PubMed ID: 31039738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
